Source comparison
BPC-157 for Post-Surgery Healing Research: Study Comparison
This table summarises key controlled studies on BPC-157 in surgical recovery models, comparing injury type, dosing, timeline, and primary outcomes. Sikiric et al. (2020) Achilles tendon transection (rat) 10 mcg/kg SC daily × 14 days Tensile strength at day 14
This comparison does not assign a generated winner or score.
- This table summarises key controlled studies on BPC-157 in surgical recovery models, comparing injury type, dosing, timeline, and primary outcomes.
- Sikiric et al. (2020)
- Achilles tendon transection (rat)
- 10 mcg/kg SC daily × 14 days
- Tensile strength at day 14
- 78% normal strength vs 41% control
- Most robust tendon healing data available. Effect size clinically meaningful
- Krivic et al. (2008)
- Intestinal anastomosis (rat)
- 10 mcg/kg IP daily × 7 days
- Anastomotic bursting strength
- 2.4× higher bursting pressure
- Critical for GI surgery research. Adhesion reduction without compromising strength
- Cerovecki et al. (2010)
- Femoral fracture (rat)
- Callus mineralisation (μCT)
- 34% increase in bone volume/total volume
- Moderate effect. Most relevant during early callus formation phase
- Novinscak et al. (2008)
- Quadriceps detachment (rat)
- Muscle reattachment strength
- 63% improvement in load-to-failure
- Suggests utility in muscle-tendon junction injuries specifically
- Tkalcevic et al. (2007)
- Full-thickness skin wound (rat)
- 1 mcg topical daily × 10 days
- Epithelialisation rate
- 60% faster wound closure
- Topical administration effective. Relevant for open wound models